Dow's Decline: Biggest Losers and Winners as Blue-chips Index Faces Q1 Loss

Seeking AlphaMar 28 18:43 ET

Vertex to Take $400M Impairment Charge as It Abandons Diabetes Drug Program

Seeking AlphaMar 28 17:19 ET

European Drug Regulator Gives Thumbs Down To Eli Lilly's Alzheimer's Drug, Analyst Says It Is Incremental Win For Biogen

BenzingaMar 28 15:34 ET

SA Asks: Which Small/mid-cap Cardiology Stocks Are Undervalued?

Seeking AlphaMar 28 15:16 ET

Liquidia Says Its Request for Yutrepia Final Approval Undergoes FDA Review

Seeking AlphaMar 28 10:05 ET

Netflix, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'

BenzingaMar 28 08:27 ET